Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-gui Yan

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Archives of Osteoporosis|January 12, 2022
Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective studyMei Li, Qun Cheng, Ya-Nan Huo, et al.
Aging Cell|July 18, 2019
Hsp90β interacts with MDM2 to suppress p53-dependent senescence during skeletal muscle regenerationMin Yi He, Shui Bo Xu, Zi Hao Qu, et al.
British Journal of Pharmacology|November 14, 2017
Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat modelChen-He Zhou, Zhong-Li Shi, Jia-Hong Meng, et al.
Frontiers in Pharmacology|April 12, 2018
Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone ResorptionChen-He Zhou, Jia-Hong Meng, Yu-Te Yang, et al.
Orthopaedic Surgery|February 20, 2013
Consensus of Chinese orthopaedic experts on diagnosis and treatment of ankylosing spondylitisBin Shen, Zhan-jun Shi, Hou-shan Lv, et al.
Molecular and Cellular Biology|October 3, 2018
Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle RegenerationWei Fan, Xiu Kui Gao, Xi Sheng Rao, et al.
Acta Pharmacologica Sinica|July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture riskHao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Archives of Osteoporosis|January 12, 2022
Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective studyMei Li, Qun Cheng, Ya-Nan Huo, et al.
Aging Cell|July 18, 2019
Hsp90β interacts with MDM2 to suppress p53-dependent senescence during skeletal muscle regenerationMin Yi He, Shui Bo Xu, Zi Hao Qu, et al.
British Journal of Pharmacology|November 14, 2017
Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat modelChen-He Zhou, Zhong-Li Shi, Jia-Hong Meng, et al.
Frontiers in Pharmacology|April 12, 2018
Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone ResorptionChen-He Zhou, Jia-Hong Meng, Yu-Te Yang, et al.
Orthopaedic Surgery|February 20, 2013
Consensus of Chinese orthopaedic experts on diagnosis and treatment of ankylosing spondylitisBin Shen, Zhan-jun Shi, Hou-shan Lv, et al.
Molecular and Cellular Biology|October 3, 2018
Hsp70 Interacts with Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 To Regulate p38MAPK Stability and Myoblast Differentiation during Skeletal Muscle RegenerationWei Fan, Xiu Kui Gao, Xi Sheng Rao, et al.
Acta Pharmacologica Sinica|July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture riskHao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
Pageof 10